Acute and chronic dosing of the GABA A alpha 2,3 selective agonist BAER-101 do not alter behavior but may impact auditory-evoked EEG responses in adults with fragile X syndrome.
- DOI
- 10.1038/s41598-026-44380-0
- Published
- 2026 Apr 1
- Container
- Scientific reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41598-026-44380-0,
title = {Acute and chronic dosing of the GABA A alpha 2,3 selective agonist BAER-101 do not alter behavior but may impact auditory-evoked EEG responses in adults with fragile X syndrome.},
author = {De Stefano LA and Kim H and Erickson CA and Pedapati EV and Dominick KC and Shaffer R and Wink LK and Schmitt LM and Miyakoshi M},
year = {2026},
journal = {Scientific reports},
doi = {10.1038/s41598-026-44380-0},
url = {https://doi.org/10.1038/s41598-026-44380-0}
}RIS
TY - JOUR TI - Acute and chronic dosing of the GABA A alpha 2,3 selective agonist BAER-101 do not alter behavior but may impact auditory-evoked EEG responses in adults with fragile X syndrome. AU - De Stefano LA AU - Kim H AU - Erickson CA AU - Pedapati EV AU - Dominick KC AU - Shaffer R AU - Wink LK AU - Schmitt LM AU - Miyakoshi M PY - 2026 JO - Scientific reports DO - 10.1038/s41598-026-44380-0 UR - https://doi.org/10.1038/s41598-026-44380-0 ER -
APA
LA, D. S., H, K., CA, E., EV, P., KC, D., R, S., LK, W., LM, S., & M, M. (2026). Acute and chronic dosing of the GABA A alpha 2,3 selective agonist BAER-101 do not alter behavior but may impact auditory-evoked EEG responses in adults with fragile X syndrome.. Scientific reports. https://doi.org/10.1038/s41598-026-44380-0